|4Feb 23, 7:07 PM ET

ARTIS DEAN RICHARD 4

4 · Annexon, Inc. · Filed Feb 23, 2026

Research Summary

AI-generated summary of this filing

Updated

Annexon (ANNX) EVP Artis Dean Richard Receives RSU and Option Grants

What Happened Artis Dean Richard, Annexon’s Executive Vice President & Chief Scientific Officer, received two equity awards on February 19, 2026: 62,500 restricted stock units (RSUs) and a 250,000-share derivative award (option grant). Both entries are reported at $0.00 per share, indicating they were granted as compensation rather than purchased. No exercise or sale occurred — these are awards/vesting arrangements, not open-market buys or sales.

Key Details

  • Transaction date: 2026-02-19; Filing date: 2026-02-23 (filed within the standard 2-business-day window).
  • Reported price: $0.00 for both the 62,500 RSUs and the 250,000-share derivative award (total reported cash outlay = $0).
  • Shares owned after transaction: not specified in the filing.
  • Footnote F1 (RSUs): 1 RSU = 1 share on vesting; 1/3 of the RSUs vest annually on Feb 19, starting Feb 19, 2027, subject to continued service.
  • Footnote F2 (derivative/option): vests 1/48th monthly beginning Feb 19, 2026, fully vesting after 4 years, subject to continued service.
  • Transaction type codes reported as A (award/grant); no indication of immediate sale, exercise, or tax-withholding in this Form 4.

Context RSU and option grants are common components of executive compensation and do not represent open-market buying or selling. The RSU award vests in annual tranches (1/3 per year), while the option-like award vests monthly over four years — meaning the insider must remain employed for vesting. Because these were grants (not purchases), they are not necessarily a direct signal of the insider’s view of short-term stock direction; they primarily reflect compensation and retention incentives.

Insider Transaction Report

Form 4
Period: 2026-02-19
ARTIS DEAN RICHARD
EVP & CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-19+62,500185,987 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-02-19+250,000250,000 total
    Exercise: $5.10Exp: 2036-02-19Common Stock (250,000 underlying)
Footnotes (2)
  • [F1]Constitute restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/3rd of the RSUs vest annually on February 19 of each year, with the first 1/3rd vesting on February 19, 2027, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.
  • [F2]1/48th of the shares subject to the option vest on each monthly anniversary measured from February 19, 2026 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to Reporting Person's continuous service with the Issuer as of each such vesting date.
Signature
/s/ Jennifer Lew, Attorney-in-Fact|2026-02-23

Documents

1 file
  • 4
    form4-02242026_120223.xmlPrimary